Immunolight, LLC

Duke University

Microelectronics Assembly Technologies, Inc.

Lambda Technologies, Inc.

Nike, Inc.

Cleanvolt Energy, Inc.

Ut-Battelle, Inc.

Lockheed Martin Energy Research Corporation

Other

Applied Materials, Inc.

North Carolina State University

Nike Innovate C.v.

Zakaryae Fathi

Frederic Avery Bourke, Jr

Harold Walder

James Elliott Clayton

Wayne F Beyer

Mark Oldham

Justus Adamson

Jianghua Wei

James Clayton

Michael J Therien

Ian Nicholas Stanton

Diane Renee Fels

Mark W Dewhirst

Wayne F Beyer, Jr

Paul Yoon

Joseph H Simmons

Richard S Garard

Robert J Lauf

Jennifer Ann Ayres

Mark DeWhirst

Joseph A Herbert

Ronald A Rudder

John James Felten

Katherine Sarah Hansen

Iftikhar Ahmad

Neil Lee Spector

Takuya Osada

John Pacanovsky

Denise A Tucker

David Alcorta

Michael Nolan

Kim Lyerly

David Heineck

Leihua Liu

April D McMillan

Paul R Stauffer

Paolo Maccarini

Joseph M Wander

Cory Robert Wyatt

Eric John Toone

Clayton R DeCamillis

Joshua T Stecher

Keith R Hicks

Felix L Paulauskas

Dave Gooden

Bruce J Kilgore

Robert L Hubbard

Michael L Hampton

William L Geisler

Jospeh H Simmons

Steve Greathouse

Roy Lynn O'Mohunddro

Richard J Petrucci

Thomas McKnight

John A Battista, Jr

Richard S Gerard

Daniel I Becker

Mark Wesley Dewhirst

Frederic A Bourke

Jr Frederic A Bourke

James Elliot Clayton

Federic A Bourke

John Pacanovski

Wayne F Bayer

A pharmaceutical composition for modifying a target structure, which includes at least one agent selected from the group consisting of energy modulation agents, plasmonics-active agents and combinations thereof; the energy modulation agents, when present, including one or more light emitters capable of emitting at least two different wavelengths of light, each wavelength of light associated with a different biological response, and the at least two different wavelengths capable of activating different biological responses; and a pharmaceutically acceptable carrier.

Non-invasive systems and methods for selective activation of photoreactive responses

A method for treating a disease in a subject in need thereof is provided involving infusing 8-methoxypsoralen (8-MOP) and a phosphor-containing drug activator into a diseased site in the subject; and delivering a dose of x-rays to the subject for production of the ultraviolet and visible light inside the subject to activate the photoactivatable drug and induce a persistent therapeutic response, the dose including a pulsed sequence of x-rays delivering from 0.5-2 Gy to the tumor, wherein the phosphor-containing drug activator includes an admixture of two or more phosphors capable of emitting ultraviolet and visible light upon interaction with x-rays; the two or more phosphors including ZnSiO:Mnand (3Ca(PO)Ca(F, Cl):Sb, Mn) at a ratio (ZnSiO:Mn):(3Ca(PO)Ca(F, Cl):Sb, Mn)) of from 1:10 to 10:1; wherein each of the two or more phosphors have at least one coating selected from an ethyl cellulose coating or a diamond-like carbon coating.

Phosphor-containing drug activator, suspension thereof, system containing the suspension, and methods for use

A dielectric material is provided. The dielectric material includes at least one layer of a substantially continuous phase material. The material is selected from the group consisting of an organic, organometallic, or combination thereof in which the substantially continuous phase material has delocalized electrons.

Use of organic and organometallic high dielectric constant material for improved energy storage devices and associated methods

An emission enhancement structure having at least one energy augmentation structure; and an energy converter capable of receiving energy from an energy source, converting the energy and emitting therefrom a light of a different energy than the received energy. The energy converter is disposed in a vicinity of the at least one energy augmentation structure such that the emitted light is emitted with an intensity larger than if the converter were remote from the at least one energy augmentation structure. Also described are various uses for the energy emitters, energy augmentation structures and energy collectors in a wide array of fields, particularly medical uses for treatment of cell proliferation disorders.

Energy augmentation structures, energy emitters or energy collectors containing the same, and their use in methods and systems for treating cell proliferation disorders

An emission enhancement structure having at least one energy augmentation structure; and an energy converter capable of receiving energy from an energy source, converting the energy and emitting therefrom a light of a different energy than the received energy. The energy converter is disposed in a vicinity of the at least one energy augmentation structure such that the emitted light is emitted with an intensity larger than if the converter were remote from the at least one energy augmentation structure. Also described are various uses for the energy emitters, energy augmentation structures and energy collectors in a wide array of fields, including various adhesives applications.

Energy augmentation structures in adhesive bonding compositions

An emission enhancement structure having at least one energy augmentation structure; and an energy converter capable of receiving energy from an energy source, converting the energy and emitting therefrom a light of a different energy than the received energy. The energy converter is disposed in a vicinity of the at least one energy augmentation structure such that the emitted light is emitted with an intensity larger than if the converter were remote from the at least one energy augmentation structure. Also described are various uses for the energy emitters, energy augmentation structures and energy collectors in a wide array of fields, especially in the field of solar cells and other energy conversion devices.

Energy augmentation structures and their use in solar cells and other energy conversion devices

A method for treating a diseased site in a human or animal body is provided which includes injecting in a diseased site one or more phosphors which are capable of emitting ultraviolet or visible light into the body;

X-ray psoralen activated cancer therapy (X-PACT)

An emission enhancement structure having at least one energy augmentation structure; and an energy converter capable of receiving energy from an energy source, converting the energy and emitting therefrom a light of a different energy than the received energy. The energy converter is disposed in a vicinity of the at least one energy augmentation structure such that the emitted light is emitted with an intensity larger than if the converter were remote from the at least one energy augmentation structure. Also described are various uses for the energy emitters, energy augmentation structures and energy collectors in a wide array of fields, such as color enhancement, and color enhancement structures containing the same.

Energy augmentation structures for use with energy emitters and collectors

Energy augmentation structures, and their use in adhesive bonding

A polymerizable composition includes at least one monomer, a photoinitiator capable of initiating polymerization of the monomer when exposed to light, and a phosphor capable of producing light when exposed to radiation (typically X-rays). The material is particularly suitable for bonding components at ambient temperature in situations where the bond joint is not accessible to an external light source. An associated method includes: placing a polymerizable adhesive composition, including a photoinitiator and energy converting material, such as a down-converting phosphor, in contact with at least two components to be bonded to form an assembly; and, irradiating the assembly with radiation at a first wavelength, capable of conversion (down-conversion by the phosphor) to a second wavelength capable of activating the photoinitiator, to prepare items such as inkjet cartridges, wafer-to-wafer assemblies, semiconductors, integrated circuits, and the like.

Adhesive bonding composition and electronic components prepared from the same

A system and method for imaging or treating a disease in a human or animal body. The system provides to the human or animal body a pharmaceutical carrier including one or more phosphors which are capable of emitting ultraviolet or visible light into the body and which provide x-ray contrast. The system includes one or more devices which infuse a diseased site with a photoactivatable drug and the pharmaceutical carrier, an initiation energy source comprising an x-ray or high energy source which irradiates the diseased site with at least one of x-rays, gamma rays, or electrons to thereby initiate emission of said ultraviolet or visible light into the body, and a processor programmed to at least one of 1) produce images of the diseased site or 2) control a dose of said x-rays, gamma rays, or electrons to the diseased site for production of said ultraviolet or visible light at the diseased site to activate the photoactivatable drug.

Tumor imaging with x-rays and other high energy sources using as contrast agents photon-emitting phosphors having therapeutic properties

Methods of treating a subject are provided, involving providing a first region of biological material coupled to the subject; initiating a change in a cellular environment of the cells in the first region; and due to a change in biological or chemical activity of the cells in the first region, inducing a biological change in a second region inside the subject, along with various biophoton collectors and biophoton bypasses useful for implementing a variety of the method embodiments.

Methods, devices, and compositions for measuring and inducing cell-to-cell communication, and therapeutic uses thereof

A method and system for treating a subject with a disorder which provides within the subject at least one photoactivatable drug for treatment of the subject, applies initiation energy from at least one source to generate inside the subject a preferential x-ray flux for generation of Cherenkov radiation (CR) light capable of activating at least one photoactivatable drug, and from the CR light, activating inside the subject the at least one photoactivatable drug to thereby treat the disorder.

Methods for radiotherapy to trigger light activation drugs

A method and a system for producing a change in a medium. The method places in a vicinity of the medium an energy modulation agent. The method applies an initiation energy to the medium. The initiation energy interacts with the energy modulation agent to directly or indirectly produce the change in the medium. The energy modulation agent has a normal predominant emission of radiation in a first wavelength range outside of a second wavelength range (WR2) known to produce the change, but under exposure to the applied initiation energy produces the change. The system includes an initiation energy source configured to apply an initiation energy to the medium to activate the energy modulation agent.

Phosphor composition having selected surface coatings

A method of and system for adhesive bonding by a) providing a polymerizable adhesive composition on a surface of an element to be bonded to form an assembly; b) irradiating the assembly with radiation at a first wavelength capable of vulcanization of bonds in the polymerizable adhesive composition by activation of sulfur-containing compound with at least one selected from x-ray, e-beam, visible, or infrared light to thereby generate ultraviolet light in the polymerizable adhesive composition; and c) adhesively joining two or more components together by way of the polymerizable adhesive composition, and a curable polymer for use therein.

Adhesive bonding composition and method of use

Growing community of inventors

Raleigh, NC, United States of America

Zakaryae Fathi